Clinical trial

Immunogenicity and Safety Study of Serum-Free Avonex

NCT00912860

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-01-01

PhasePHASE2

Study timeline

Study start (unknown)2003-01-01Date precision: month

Registry last updated2009-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Interferon beta-1aDRUG · verified · RxNorm: interferon beta-1a

Sponsors & collaborators

Biogenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00912860 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.